SEC Form 4 · accession 0001213607-15-000001
EASTGATE BIOTECH CORP · ETBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Schwarz
Officer — CSO
Period of report
Jan 5, 2015
Accepted (ET)
Jan 21, 2015 · 2:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099574
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON SHARES | Jan 5, 2015 | P | 1,121,250 | $0.04 | A | 8,724,114 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WARRANT | $0.04 | Jan 5, 2015 | P | 1,121,250 | A | Jan 5, 2015 | Jan 5, 2020 | COMMON SHARES | 1,121,250 | 1,517,250 | D |